Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
COVID-19: Page 2
COVID-19 fraud conviction overturned by federal judge
By
LabPulse.com staff writers
A federal judge has overturned a jury verdict convicting a Maryland doctor of five counts of COVID-19 testing fraud.
January 9, 2024
CEO of Decision Diagnostics pleads guilty in COVID-19 test fraud scheme
By
LabPulse.com staff writers
The CEO and sole director of Decision Diagnostics has pleaded guilty to securities fraud, wire fraud, and obstruction of an official proceeding in connection with false claims of the firm developing a rapid COVID-19 test early in the pandemic.
December 11, 2023
Texas lab owner pleads guilty in $1.7M Medicare fraud
By
LabPulse.com staff writers
A Plano, TX, lab owner has pleaded guilty to orchestrating a scheme to obtain $1.7 million from Medicare fraudulently, announced the office of the U.S. Attorney for the Northern District of Texas in a statement.
December 6, 2023
AI model shows promise detecting COVID-19 in low-resource settings
By
Will Morton
An artificial intelligence (AI) model shows promise for diagnosing COVID-19 in low-resource settings with severe shortages of medical experts, including in many African regions, according to a study published November 11 in
Scientific Reports
.
November 14, 2023
3EO Health to launch FDA-approved COVID-19 test
By
Matt Limb
Molecular diagnostics startup 3EO Health is preparing to launch a newly approved SARS-CoV-2 test with its portable molecular device, saying it will “expand access” to the technology.
October 20, 2023
Researchers develop technique for onsite detection of SARS-CoV-2
By
LabPulse.com staff writers
Researchers have developed a portable laboratory device for rapid onsite detection of SARS-CoV-2 RNA which holds promise for scenarios in which there is no or limited access to testing laboratories.
October 10, 2023
FDA issues EUAs for 2 POC COVID-19 tests
By
LabPulse.com staff writers
The U.S. Food and Drug Administration (FDA) granted emergency use authorizations (EUAs) for two separate point-of-care (POC) assays for SARS-CoV-2 developed by Tangen Biosciences and SD Biosensor.
October 4, 2023
Study launched on early intervention with immune modulators in COVID-19
By
LabPulse.com staff writers
A clinical trial has been launched to determine if there are benefits to early intensive immune modulation for hospitalized COVID-19 patients with relatively mild illness.
September 26, 2023
U.S. government investing $600M in COVID-19 test manufacturing
By
LabPulse.com staff writers
The U.S. Department of Health and Human Services announced that it is investing $600 million in funding into COVID-19 test manufacturing.
September 26, 2023
Report: Lack of standardization a ‘huge’ issue during pandemic, problems persist
By
Nick Paul Taylor
A lack of standardization of infectious disease consumables was “a huge, unanticipated issue during the pandemic” that still needs to be resolved, according to a report in GenomeWeb.
September 15, 2023
Whistleblower claims CIA analysts were bribed to reject COVID-19 'lab leak' origin hypothesis
By
LabPulse.com staff writers
A whistleblower gave testimony to two panels of the House of Representatives alleging that six CIA analysts were bribed to reject the theory that the COVID-19 pandemic resulted from a research-related leak of a new coronavirus.
September 15, 2023
Study: Blood clotting proteins may contribute to COVID-19 'brain fog,' cognitive problems
By
Matt Limb
The presence of blood clots may help explain cognitive problems such as "brain fog" in patients following COVID-19 infection, say researchers.
September 13, 2023
Previous Page
Page 2 of 35
Next Page